Correlation Between HTG Molecular and SeqLL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HTG Molecular and SeqLL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HTG Molecular and SeqLL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HTG Molecular Diagnostics and SeqLL Inc, you can compare the effects of market volatilities on HTG Molecular and SeqLL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HTG Molecular with a short position of SeqLL. Check out your portfolio center. Please also check ongoing floating volatility patterns of HTG Molecular and SeqLL.

Diversification Opportunities for HTG Molecular and SeqLL

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between HTG and SeqLL is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding HTG Molecular Diagnostics and SeqLL Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SeqLL Inc and HTG Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HTG Molecular Diagnostics are associated (or correlated) with SeqLL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SeqLL Inc has no effect on the direction of HTG Molecular i.e., HTG Molecular and SeqLL go up and down completely randomly.

Pair Corralation between HTG Molecular and SeqLL

Given the investment horizon of 90 days HTG Molecular is expected to generate 4.2 times less return on investment than SeqLL. But when comparing it to its historical volatility, HTG Molecular Diagnostics is 1.01 times less risky than SeqLL. It trades about 0.01 of its potential returns per unit of risk. SeqLL Inc is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  40.00  in SeqLL Inc on August 29, 2024 and sell it today you would lose (1.00) from holding SeqLL Inc or give up 2.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

HTG Molecular Diagnostics  vs.  SeqLL Inc

 Performance 
       Timeline  
HTG Molecular Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HTG Molecular Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, HTG Molecular is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
SeqLL Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SeqLL Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, SeqLL is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

HTG Molecular and SeqLL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HTG Molecular and SeqLL

The main advantage of trading using opposite HTG Molecular and SeqLL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HTG Molecular position performs unexpectedly, SeqLL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SeqLL will offset losses from the drop in SeqLL's long position.
The idea behind HTG Molecular Diagnostics and SeqLL Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stocks Directory
Find actively traded stocks across global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Transaction History
View history of all your transactions and understand their impact on performance